Kelly Carroll

Kelly Carroll is an accomplished professional with extensive experience in the pharmaceutical and venture capital sectors. Currently serving as a Mentor/Coach at Nucleate Switzerland and the Innovation Office University of Basel, Carroll also acts as a Limited Partner at Asymmetry Ventures, N49P Ventures, and LAUNCH, while contributing as a Business Angel for Swiss Health Angels. Previous roles include Transition Leader for the Sandoz spinoff from Novartis and Global Launch Excellence Director at Novartis, where Carroll developed innovative frameworks to enhance product launch readiness. Earlier experience at Astellas Pharma Europe included significant leadership positions in operational strategy and commercial risk management. Carroll holds multiple degrees from prestigious institutions, including an MBA from Alliance Manchester Business School and advanced marketing qualifications from CIM.